Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
about
The impact of comorbidity on cancer and its treatmentNecrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptionsChoice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort studyUsing ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)The effect of resistance exercise on all-cause mortality in cancer survivors.Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions.A systematic literature review of life expectancy prediction tools for patients with localized prostate cancerSurvival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.The impact of state-specific life tables on relative survival.Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC.Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States.Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.Individualized estimates of overdiagnosis in screen-detected prostate cancer.Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancerVitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants.Decreased cancer-independent life expectancy in the head and neck cancer population.Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).On the choice of time scales in competing risks predictions.Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995-2011.Association between age and survival in a cohort of Brazilian patients with operable breast cancer.Psychometric characteristics of the Muslim Religiosity Scale in Iranian patients with cancer.Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.Predictors of recurrent hospital admissions among prostate cancer survivors.Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008-2013 from a population-based cancer registry.Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone.Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.Healthy Living After Cancer Treatment: Considerations for Clinical and Community Practice
P2860
Q26764935-EB5E0DA3-2535-47A7-892D-A030C8306873Q28652643-181F4ABF-7677-4D97-91DB-27F360CBA83FQ33869184-859AD109-28F7-4FC5-8938-D8E797E40956Q33900866-AAC1AEAE-FA16-43A2-9FB2-EA30EC9CABB2Q34019217-D0773F82-8B96-49D4-A5FC-0148785BB985Q34031286-908ADCCC-0633-42D0-89E7-F45103A138B9Q35852490-22E288F9-97AE-4BE2-9E36-9191B543830EQ35858307-271F65C5-D37C-49DB-B141-41A50776EABCQ36023388-1A44CB2F-B837-457D-ABFD-689229561AE0Q36093830-944F3A0B-58D4-4A02-B5C5-52C6D438ED66Q36826211-85BBCB48-398E-419B-9C36-55E89F51AC10Q36826214-412C8416-F212-46AB-A4E8-75AA221486ABQ37066250-8F3534C8-F136-4C60-A155-1FA38D2E37F1Q37601809-6B95FD3D-D488-4B76-9859-6EEF1C2B8AB7Q37634486-634E71EF-9533-489E-8024-9258ED94142AQ37722447-20212FAE-4B80-44BB-9852-B05D21B1D04AQ37722698-E95DAC89-73CA-4C0B-BD52-266D64706B69Q38713969-E0D34702-AF0C-4BC3-BECC-BC581B36038CQ38863741-5163BD45-5453-4533-977C-4589EDB859C2Q39661532-3F0519EB-7584-48E8-BC41-0C6F97FB4F92Q40504173-2E4AA9C5-75B3-4392-98D1-AE1D0A1B8435Q41111232-DCDF24F8-0DF6-40DF-A068-FB29AB580846Q41353024-77AD90E3-18F4-4F43-A823-81B17785F6E7Q47439083-D0A32E81-5825-4F08-B3AB-2D83789E1406Q47779231-ADCA6A52-526F-4D97-9A76-3DACA4A97179Q48332247-602623D7-4D5D-4E11-BD09-969F76CE6C66Q48333499-A16E5519-9D9D-47CC-80FC-DE5C82CD95B9Q50019712-06358321-2C2A-4101-B2F4-87194F574AE3Q50193948-8029A2BC-DF68-46AD-A5ED-CD19B9D4A2D0Q57148110-86FC3062-E30F-4490-B851-AE11AF755383
P2860
Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@en
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@nl
type
label
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@en
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@nl
prefLabel
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@en
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@nl
P2093
P2860
P356
P1476
Assessing non-cancer-related h ...... al and comorbidity prevalence.
@en
P2093
Angela B Mariotto
Bhupinder S Mann
Carrie N Klabunde
Eric J Feuer
Hyunsoon Cho
P2860
P304
P356
10.1093/AJE/KWS580
P407
P577
2013-07-03T00:00:00Z